Cargando…

Association of Mu-Opioid Receptor(MOR) Expression and Opioids Requirement With Survival in Patients With Stage I-III Pancreatic Ductal Adenocarcinoma

BACKGROUND: The use of opioids in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) is associated with shorter survival and not dependent on the expression of the mu-opioid receptor (MOR). The role of opioid use and MOR expression in stage I-III PDAC has not been investigated. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hao, Qu, Mengdi, Gorur, Aysegul, Sun, Zhirong, Cata, Juan P., Chen, Wankun, Miao, Changhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249918/ https://www.ncbi.nlm.nih.gov/pubmed/34222012 http://dx.doi.org/10.3389/fonc.2021.686877

Ejemplares similares

Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia
por: Oladosu, Folabomi A., et al.
Publicado: (2015)

Association of Mu-Opioid Receptor Expression With Long-Term Survival and Perineural Nerve Invasion in Patients Undergoing Surgery for Ovarian Cancer
por: Zhang, Hao, et al.
Publicado: (2022)

Vimentin interacts with the 5′-untranslated region of mouse mu opioid receptor (MOR) and is required for post-transcriptional regulation
por: Song, Kyu Young, et al.
Publicado: (2013)

Role of efficacy as a determinant of locomotor activation by mu‐opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR‐selective phenylmorphans with high‐to‐low MOR efficacy
por: Santos, Edna J., et al.
Publicado: (2023)

Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene
por: Chen, Shiou-Lan, et al.
Publicado: (2010)

Mu Opioid Receptor 1 (MOR-1) Expression in Colorectal Cancer and Oncological Long-Term Outcomes: A Five-Year Retrospective Longitudinal Cohort Study
por: Díaz-Cambronero, Oscar, et al.
Publicado: (2020)

Effects of Intravenous Infusion of Lidocaine on Short-Term Outcomes and Survival in Patients Undergoing Surgery for Ovarian Cancer: A Retrospective Propensity Score Matching Study
por: Zhang, Hao, et al.
Publicado: (2022)

Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice
por: Negus, S. Stevens, et al.
Publicado: (2023)

Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene
por: Kim, Chun Sung, et al.
Publicado: (2006)

MOR Is Not Enough: Identification of Novel mu-Opioid Receptor Interacting Proteins Using Traditional and Modified Membrane Yeast Two-Hybrid Screens
por: Petko, Jessica, et al.
Publicado: (2013)

Beyond Mor: Can Induction of Dopamine Homeostasis Along with Electrotherapy Attenuate the Opioid Crisis?
por: Blum, Kenneth, et al.
Publicado: (2023)

Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands
por: Harland, Aubrie A., et al.
Publicado: (2016)

Review: The Emerging Role of Neutrophil Extracellular Traps in Sepsis and Sepsis-Associated Thrombosis
por: Chen, Zhaoyuan, et al.
Publicado: (2021)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts
por: Dinarvand, Amin, et al.
Publicado: (2014)

Neutrophil extracellular traps mediate m(6)A modification and regulates sepsis-associated acute lung injury by activating ferroptosis in alveolar epithelial cells
por: Zhang, Hao, et al.
Publicado: (2022)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer
por: Jorand, Raphael, et al.
Publicado: (2016)

PKM2 is not required for pancreatic ductal adenocarcinoma
por: Hillis, Alissandra L, et al.
Publicado: (2018)

Mu Opioid Receptor Actions in the Lateral Habenula
por: Margolis, Elyssa B., et al.
Publicado: (2016)

Comparison of physicochemical properties and biological activities of opioid morphinans interacting with mu opioid receptors
por: Asim, Muhammad F, et al.
Publicado: (2008)

Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits
por: Kim, Brian S., et al.
Publicado: (2022)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D(2) Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
por: Vasudevan, Lakshmi, et al.
Publicado: (2019)

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions
por: Liu, Shan, et al.
Publicado: (2021)

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

Mu opioid receptors on vGluT2‐expressing glutamatergic neurons modulate opioid reward
por: Reeves, Kaitlin C., et al.
Publicado: (2020)

Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor
por: Smith, Mark A., et al.
Publicado: (2022)

Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor
por: Zhang, Jia‐Jia, et al.
Publicado: (2022)

Opioids, sleep, analgesia and respiratory depression: Their convergence on Mu (μ)-opioid receptors in the parabrachial area
por: Lynch, Nicole, et al.
Publicado: (2023)

Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation
por: Coluzzi, Flaminia, et al.
Publicado: (2022)

Mu opioid receptor: from pain to glucose metabolism
por: Tudurí, Eva, et al.
Publicado: (2016)

Dual single-scission event analysis of constitutive transferrin receptor (TfR) endocytosis and ligand-triggered β2-adrenergic receptor (β2AR) or Mu-opioid receptor (MOR) endocytosis
por: Lampe, Marko, et al.
Publicado: (2014)

Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade
por: Trøstheim, Martin, et al.
Publicado: (2022)

Endogenous Opioid Peptides and Alternatively Spliced Mu Opioid Receptor Seven Transmembrane Carboxyl-Terminal Variants
por: Abrimian, Anna, et al.
Publicado: (2021)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

Pomegranate-derived anthocyanin regulates MORs-cAMP/CREB-BDNF pathways in opioid-dependent models and improves cognitive impairments
por: Ridzwan, Norhaslinda, et al.
Publicado: (2020)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_14nqf7rh8l64i62asrm1kvsm2j